Edwards Lifesciences (EW) Short-Term Debt issuances (2010 - 2013)

Edwards Lifesciences' Short-Term Debt issuances history runs 4 years deep, the most recent figure standing at $372.9 million for Q3 2013.

• In Q3 2013, Short-Term Debt issuances rose 775.35% year-over-year to $372.9 million; the TTM figure through Sep 2013 stood at $900.5 million (up 149.45% YoY), while the FY2012 annual figure was $407.0 million, down 22.64% from the prior year.
• Short-Term Debt issuances for Q3 2013 stood at $372.9 million, up from $173.9 million in the prior quarter.
• The five-year high for Short-Term Debt issuances was $372.9 million in Q3 2013, with the low at $5.2 million in Q1 2011.
• The 4-year median for Short-Term Debt issuances is $108.2 million (2010), against an average of $129.4 million.
• The sharpest annual moves came in 2011 and 2012: Short-Term Debt issuances slumped 91.93% in 2011, then jumped 2815.38% in 2012.
• Edwards Lifesciences' Short-Term Debt issuances stood at $95.2 million in 2010, then surged by 56.93% to $149.4 million in 2011, then surged by 30.79% to $195.4 million in 2012, then soared by 90.84% to $372.9 million in 2013.
• Business Quant data shows EW's Short-Term Debt issuances at $372.9 million in Q3 2013, $173.9 million in Q2 2013, and $158.3 million in Q1 2013.